FUNCTIONAL AND MECHANISTIC STUDIES OF DNA TOPOISOMERASES
FUNCTIONAL AND MECHANISTIC STUDIES OF DNA TOPOISOMERASES
批准号:
6385380
负责人:
LEROY F LIU
金额:
$30.88万
依托单位国家:
美国
项目类别:
财政年份:
1980
资助国家:
美国
项目状态:
已结题
起止时间:
1980-04-01 至 2002-06-30
关键词:
DNA damage DNA topoisomerases Drosophilidae Escherichia coli Saccharomyces cerevisiae alternatives to animals in research apoptosis bacterial genetics enzyme mechanism fungal genetics genetic promoter element hydrogen peroxide molecular cloning nucleic acid structure oxidative stress protein binding protein isoforms site directed mutagenesis thiols transcription factor yeast two hybrid system
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Our long-term objective is to understand the molecular mechanism and
physiological function of multiple DNA topoisomerases. In the current
application, we propose to study the roles of the two human topoisomerase
II (TOP2) isoforms in chromosomal loop domain organization and apoptotic
cell death. Many TOP2-targeted anti-cancer drugs are known to induce
apoptotic cell death and high molecular weight (HMW) DNA fragmentation
(about 50 kb). These HMW DNA fragments presumably reflect TOP2-mediated
excision of chromosomal loop domains in which TOP2 is located at their
loop anchorage sites. Strikingly, a similar pattern of HMW DNA
fragmentation (predominantly 50 kb) has also been observed in apoptotic
cells induced by diverse stimuli many of which are known to induce
oxidative stress. The HMW DNA fragmentation has been suggested to be a
committed step in the apoptotic cell death process, but the enzyme
responsible for HMW DNA fragmentation has not been identified. Our
preliminary studies have demonstrated that the two human DNA TOP2
isoforms, TOP2a and TOP2b, can be activated to become DNA cleaving
"nucleases" by hydrogen peroxide, a reactive oxygen species (ROS) produced
during oxidative stress. Oxidative stress has been suggested to be a
potential cellular activation of TOP2b (and/or TOP2a) by hydrogen peroxide
during oxidative stress is responsible for HMW DNA fragmentation in
apoptotic cells. There are two major specific aims for the current
application; (1). Functional studies of human TOP2 isoforms. Two
approaches will be employed, identification of TOP2-interacting proteins
and generating dominant negative mutant TOP2 cell lines. In addition to
testing the roles of TOP2 isoforms in chromosomal loop domains mutated in
patients with the Bloom's syndrome (genome instability) and WRN, mutated
in patients with the Werner's syndrome (premature aging). (2). To
establish the roles of human TOP2 isoforms in HMW DNA fragmentation during
apoptotic cell death. We will determine if TOP2 ( and which TOP2 isoform)
is activated into a "nuclease" in cells treated with hydrogen peroxide or
other agents. We will also determine which TOP2 isoform is responsible for
HMW DNA fragmentation during apoptotic cell death.
期刊论文(38)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
In vivo mapping of DNA topoisomerase II-specific cleavage sites on SV40 chromatin.
SV40 染色质上 DNA 拓扑异构酶 II 特异性切割位点的体内作图。
DOI:
10.1016/0092-8674(85)90067-4
发表时间:
1985
期刊:
Cell
影响因子:
64.5
作者:
[Yang,L, Rowe,TC, Nelson,EM, Liu,LF]
通讯作者:
Liu,LF
A protein factor from Xenopus oocytes with simian virus 40 large tumor antigen-like DNA supercoiling activity.
来自非洲爪蟾卵母细胞的蛋白质因子,具有猿猴病毒 40 大肿瘤抗原样 DNA 超螺旋活性。
DOI:
10.1073/pnas.87.23.9078
发表时间:
1990
期刊:
Proceedings of the National Academy of Sciences of the United States of America
影响因子:
11.1
作者:
[Zhang,H, Jessee,CB, Liu,LF]
通讯作者:
Liu,LF
Evidence for the reversibility of cellular DNA lesion induced by mammalian topoisomerase II poisons.
哺乳动物拓扑异构酶 II 毒物诱导的细胞 DNA 损伤具有可逆性的证据。
DOI:
--
发表时间:
1989
期刊:
The Journal of biological chemistry
影响因子:
--
作者:
[Hsiang,YH, Liu,LF]
通讯作者:
Liu,LF
DOI:
--
发表时间:
1988-06
期刊:
Cancer research
影响因子:
11.2
作者:
[Y. Hsiang;Hai-Young Wu;Leroy F. Liu]
通讯作者:
Y. Hsiang;Hai-Young Wu;Leroy F. Liu
DOI:
10.1016/s0021-9258(17)47282-6
发表时间:
1984
期刊:
The Journal of biological chemistry
影响因子:
--
作者:
[K. M. Tewey;G. L. Chen;E. Nelson;L. Liu]
通讯作者:
K. M. Tewey;G. L. Chen;E. Nelson;L. Liu
共 24 条
Training in Cancer Pharmacology
-
批准号:7128170
-
项目类别:
-
资助金额:$36.81万
-
财政年份:2005
-
负责人:LEROY F LIU
-
依托单位:
Training in Cancer Pharmacology
-
批准号:6894915
-
项目类别:
-
资助金额:$18.16万
-
财政年份:2005
-
负责人:LEROY F LIU
-
依托单位:
Training in Cancer Pharmacology
-
批准号:7292666
-
项目类别:
-
资助金额:$32.99万
-
财政年份:2005
-
负责人:LEROY F LIU
-
依托单位:
Training in Cancer Pharmacology
-
批准号:7681012
-
项目类别:
-
资助金额:$12.94万
-
财政年份:2005
-
负责人:LEROY F LIU
-
依托单位:
Training in Cancer Pharmacology
-
批准号:7498567
-
项目类别:
-
资助金额:$27.63万
-
财政年份:2005
-
负责人:LEROY F LIU
-
依托单位:
Mechanism of Action of TOP2-Directed Anticancer Drugs
-
批准号:8129544
-
项目类别:
-
资助金额:$29.5万
-
财政年份:2004
-
负责人:LEROY F LIU
-
依托单位:
Mechanism of Action of TOP2-Directed Anticancer Drugs
-
批准号:7526710
-
项目类别:
-
资助金额:$28.11万
-
财政年份:2004
-
负责人:LEROY F LIU
-
依托单位:
Mechanism of action of TOP2-directed anticancer drugs
-
批准号:7006957
-
项目类别:
-
资助金额:$28.02万
-
财政年份:2004
-
负责人:LEROY F LIU
-
依托单位:
Mechanism of action of TOP2-directed anticancer drugs
-
批准号:6782758
-
项目类别:
-
资助金额:$28.69万
-
财政年份:2004
-
负责人:LEROY F LIU
-
依托单位:
Mechanism of Action of TOP2-Directed Anticancer Drugs
-
批准号:8307026
-
项目类别:
-
资助金额:$23.21万
-
财政年份:2004
-
负责人:LEROY F LIU
-
依托单位:
Mechanism of Action of TOP2-Directed Anticancer Drugs
-
批准号:7669433
-
项目类别:
-
资助金额:$28.95万
-
财政年份:2004
-
负责人:LEROY F LIU
-
依托单位:
Mechanism of Action of TOP2-Directed Anticancer Drugs
-
批准号:7869327
-
项目类别:
-
资助金额:$29.53万
-
财政年份:2004
-
负责人:LEROY F LIU
-
依托单位:
Mechanism of action of TOP2-directed anticancer drugs
-
批准号:7194334
-
项目类别:
-
资助金额:$27.2万
-
财政年份:2004
-
负责人:LEROY F LIU
-
依托单位:
Mechanism of action of TOP2-directed anticancer drugs
-
批准号:6868144
-
项目类别:
-
资助金额:$28.69万
-
财政年份:2004
-
负责人:LEROY F LIU
-
依托单位:
Mechanism of Action of TOP2-Directed Anticancer Drugs
-
批准号:8700947
-
项目类别:
-
资助金额:$6.58万
-
财政年份:2004
-
负责人:LEROY F LIU
-
依托单位:
Topoisomerase I-directed Anticancer Drugs
-
批准号:6687804
-
项目类别:
-
资助金额:$27.95万
-
财政年份:1998
-
负责人:LEROY F LIU
-
依托单位:
PROTOBERBERINES AS DUAL POISONS OF TOPOISOMERASES
-
批准号:6173399
-
项目类别:
-
资助金额:$22.6万
-
财政年份:1998
-
负责人:LEROY F LIU
-
依托单位:
Topoisomerase I-directed Anticancer Drugs
-
批准号:6621894
-
项目类别:
-
资助金额:$27.95万
-
财政年份:1998
-
负责人:LEROY F LIU
-
依托单位:
Topoisomerase I-directed Anticancer Drugs
-
批准号:6437280
-
项目类别:
-
资助金额:$27.95万
-
财政年份:1998
-
负责人:LEROY F LIU
-
依托单位:
PROTOBERBERINES AS DUAL POISONS OF TOPOISOMERASES
-
批准号:2896423
-
项目类别:
-
资助金额:$21.94万
-
财政年份:1998
-
负责人:LEROY F LIU
-
依托单位:
海外基金